好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Immunomodulatory Drug Treatment in Multiple Sclerosis: Effect on Survival
MS and Related Diseases
(-)
148
Authors/Disclosures
David Orion No disclosure on file
Joab Chapman, MD, PhD (Sheba Medical Center) Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Mark Dolev Dolgopiat, MD No disclosure on file
Rakefet Tsabari, MD (Brookhaven National Labs) No disclosure on file
Anat Achiron, MD, PhD, FAAN (Sheba Medical Center, Tel-Hashomer) Dr. Achiron has nothing to disclose.
No disclosure on file